Seedling News Square

From environmental projects characterizing and quantitating contaminants in our water, food and even inside us, to infectious disease projects addressing antimicrobial resistance, “one of the world’s most urgent public health problems”, and studying factors that contribute to emerging infections, these seed grant-supported projects span a wide range of fields.


One project may result in improved clinical testing, while others build on our foundational scientific understanding, translating into practice in the future.


Several projects involve collaboration with other Wadsworth Center researchers, and all were presented during well-attended speed-talks to the Wadsworth community. 


No matter the field, or whether the research is basic or translational, it is all in support of public health, and therefore, quintessentially Wadsworth Center.


Funded by Health Research Incorporated (HRI)

For over 70 years, HRI has partnered with the New York State Department of Health to assist with administrative and programmatic support for public health and research programs. As part of their mission to support and extend the functions of the Wadsworth Center, HRI awarded seed funding in Fiscal Year 2025. 


Over 20 proposals were submitted from investigators all around the Center in response to the award announcement and, following review, the HRI Scientific Advisory Board selected nine for funding. This funding enables the Center’s researchers to pursue new research paths, equips them to perform critical scientific laboratory work, and supports dissemination of their findings and future grant proposals. 

Alex Ciota, Ph.D.

Alex Ciota, PhD

Understanding how temperature and humidity interact to influence mosquito fitness and West Nile virus (WNV) transmission


This project strikes out in a new direction for the Ciota Lab. Traditionally focusing on the genetics of the virus, they now turn to the mosquitoes themselves, trying to understand moisture as an environmental driver of transmission. With the award, they will purchase humidity-controlled incubators that simulate current and predicted environmental levels of relative humidity. This will allow the lab to assess the impact of humidity on transmission, vector competence, biting rate and lifespan. These data will enable development of risk-based maps of regional predictions that inform public health actions.
 

Brian Duffy, Ph.D.

Brian Duffy, PhD

Identification and Quantitation of Contaminant Siloxanes in Drinking and Surface Waters


The use of siloxanes as cleaning agents of unknown toxicity has exploded in recent years. Methods currently exist to detect siloxanes in cosmetics, food and more. In Europe strict siloxane levels have been set; however, environmental levels, especially in drinking and surface waters, are unknown. Dr. Duffy has taken on the challenge of developing extraction and quantitation methods that overcome these hurdles.
 

Nicholas Mantis, Ph.D. and Sudha Chaturvedi, Ph.D.

Nicholas Mantis, PhD            Sudha Chaturvedi, PhD

 

Antibody-based medical countermeasures for multidrug resistant Candida auris


This relatively new pathogen crashed onto the scene only 15 years ago, with many C. auris infections resistant to nearly all traditional treatments and with a 60% mortality rate in NY. Drs. Mantis and Chaturvedi are working to discover new antibody-based avenues to treat the infections, in addition to developing approaches to stopping the spread of the infection. Studies have shown that C. auris is salt tolerant, surviving in sweat glands and hair follicles, so they are trying to better understand host/pathogen dynamics in the skin, potentially leading to a topical treatment that would interrupt transmission.
 

Jon Paczkowski, Ph.D.

Jon Paczkowski, PhD

Exploring the role of protein-protein interactions in controlling promoter selection and gene expression of LuxR-type transcription factors in pathogenic bacteria


An unexpected discovery in Dr. Paczkowski’s Lab has them collaborating with fellow Wadsworth Center researchers, upending the paradigm held for 30 years that small signal molecules had to surpass a certain threshold to turn on/off genes involved in pathogenesis. Dr. Paczkowski believes regulation is not like an on/off switch, but rather a dimmer switch, and they are studying multiple pathogenic organisms to prove it.
 

Brian Duffy, Ph.D.

Brian Duffy, PhD

Not pictured: Lingyun Li, PhD

Characterization of the Incorporation of Both Free and Covalently Bound Perfluoroalkyl Carboxylic Acids (PFCA's) into Plant and Mammal Triglycerides and Phosphatidyl Cholines


Carpet, clothing, food packaging, dust and even drinking water may contain PFCA’s. In their free form, PFCAs are believed to interfere with biological processes such as increasing cholesterol levels. Drs. Duffy and Li are examining if free PFCA’s are biomimetic building blocks and are accidentally incorporated into triglycerides and cell walls.
 

Pallavi Ghosh, Ph.D.

Pallavi Ghosh, PhD

Characterization of WhiB proteins in Mycobacterium abscessus


M. abscessus is a highly antibiotic resistant, opportunistic pathogen of special concern for those with cystic fibrosis. Antibiotic exposure leads to an induction of a large number of genes, several of which are under the control of WhiB7. Dr. Ghosh is studying the role of the WhiB family of proteins in cellular processes and antibiotic resistance.  
 

Todd Gray, Ph.D.

Todd Gray, PhD

Functional Membrane Microdomains in Mycobacteria


Dr. Gray proposes to determine whether the membranes of mycobacteria have specialized microdomains that form sites of protein secretion. He will focus on a class of proteins called flotillins, which he proposes are localized to membrane microdomains and are important for contact dependent cell-cell signaling. Flotillins are conserved in other mycobacteria, suggesting their function--and microdomains--are relevant to pathogenic species.
 

Jennifer Yates, Ph.D.

Jennifer Yates, PhD Photo credit University at Albany Office of Communications and Marketing

Development of a Novel Multiplex Serology Assay for the Diagnosis of Chagas Disease 


Chagas disease, also known as American Trypanosomiasis, is caused by the parasite T. cruzi. Chronic infection with the parasite is life-long and largely asymptomatic, resulting in delayed access to treatment, congenital infections, and potential contamination of the blood and organ supply. This project seeks to develop a single test, which is both sensitive and specific to this genetically diverse pathogen.
 

Jon Paczkowski, PhD    Anil Ojha, PhD

 

 

 

 

 

Community dynamics of the lung pathogens Mycobacterium abscessus and Pseudomonas aeruginosa


P. aeruginosa is a common cause of lung infections, but often not alone. Co-infection with M. abscessus is frequent. When these two are grown together in the lab, changes in ribosome structure, gene transcription and other chemical processes are observed in M. abscessus. It is known that Pseudomonas cells “communicate” among themselves by quorum sensing, but Drs. Paczkowski and Ojha will investigate whether they may also be “communicating” with M. abscessus and if that causes the changes observed.
 

More News